Friday 6 November 2026 Export MCK’s income statement to Excel — free account

McKesson Corporation

McKesson Corporation’s revenue for fiscal 2026 (year ended March 2026) was $403.4 billion, up 12.4% from fiscal 2025.

Revenue: +7.57%
EPS: +17.0%
Free cash flow: +32.5%
Total debt: +7.08%

Quarter to September 2026, against a year earlier

1,074.06 4.62 +0.43%

Follow MCK

Alert me

Market cap: $125.0B
P/E: 27.5×
Fwd P/E: 25.4×
Dividend yield: 0.32%
F-score: 7/9
Altman Z: 6.15
Beneish M: −2.34
Dividend safety: 86/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

McKesson Corporation (MCK) revenue by segment, product and region

Where the money comes from and where it goes

Fiscal 2026: revenue by segment, and margins
North American Pharmaceutical	336,652	83.45%
Oncology & Multispecialty	48,423	12.00%
Medical-Surgical Solutions	11,507	2.85%
Prescription Technology Solutions	5,805	1.44%
Gross margin		3.61%
Operating margin		1.54%
Pre-tax margin		1.54%

Revenue by segment $m

Line	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2011	FY2010
North American Pharmaceutical	336,652 83.45%	304,507 84.81%	261,368 84.60%	—	—	—	—	—	—	—	—	—	—	—	—
Oncology & Multispecialty	48,423 12.00%	36,862 10.27%	30,490 9.87%	—	—	—	—	—	—	—	—	—	—	—	—
Medical-Surgical Solutions	11,507 2.85%	11,380 3.17%	11,309 3.66%	11,110 4.02%	11,608 4.40%	10,099 4.24%	8,305 3.59%	7,618 3.55%	6,611 3.17%	6,244 3.15%	—	—	—	—	—
Prescription Technology Solutions	5,805 1.44%	5,216 1.45%	4,769 1.54%	4,387 1.59%	3,864 1.46%	2,890 1.21%	2,705 1.17%	2,489 1.16%	—	—	—	—	—	—	—
U.S. Pharmaceutical	—	—	—	240,616 86.96%	212,149 80.37%	189,274 79.45%	181,700 78.64%	166,189 77.54%	—	—	—	—	—	—	—
International	—	—	—	20,598 7.44%	36,345 13.77%	35,965 15.10%	38,341 16.59%	38,023 17.74%	38,414 18.44%	34,105 17.18%	32,629 17.09%	36,235 20.24%	14,966 10.89%	—	—
U.S. Pharmaceutical and Specialty Solutions	—	—	—	—	—	—	—	—	162,587 78.03%	155,236 78.19%	—	—	—	—	—
European Pharmaceutical Solutions	—	—	—	—	—	—	—	—	27,320 13.11%	24,847 12.52%	—	—	—	—	—
Other Segments	—	—	—	—	—	—	—	—	11,839 5.68%	12,206 6.15%	—	—	—	—	—
Distribution Solutions	—	—	—	—	—	—	—	—	—	—	187,999 98.49%	175,976 98.29%	134,062 97.58%	108,889 97.15%	105,578 97.13%
Technology Solutions	—	—	—	—	—	—	—	—	—	—	2,885 1.51%	3,069 1.71%	3,330 2.42%	3,195 2.85%	3,124 2.87%
Also reported: a second breakdown of the same revenue
Distribution Solutions Direct Distribution And Services	—	—	—	—	—	—	—	—	—	—	—	—	—	77,554 69.19%	72,210 66.43%
Distribution Solutions Sales To Customers Warehouses	—	—	—	—	—	—	—	—	—	—	—	—	—	18,631 16.62%	21,435 19.72%
Distribution Solutions Canada Pharmaceutical Distribution And Services	—	—	—	—	—	—	—	—	—	—	—	—	—	9,784 8.73%	9,072 8.35%
Distribution Solutions Medical Surgical Distribution And Services	—	—	—	—	—	—	—	—	—	—	—	—	—	2,920 2.61%	2,861 2.63%
Technology Solutions Services	—	—	—	—	—	—	—	—	—	—	—	—	—	2,483 2.22%	2,439 2.24%
Technology Solutions Software And Software Systems	—	—	—	—	—	—	—	—	—	—	—	—	—	590 0.53%	571 0.53%
Technology Solutions Hardware	—	—	—	—	—	—	—	—	—	—	—	—	—	122 0.11%	114 0.10%
Eliminations	—	—	—	—	—	—	—	—	(38,414) (18.44%)	(34,105) (17.18%)	(32,629) (17.09%)	(36,235) (20.24%)	(14,966) (10.89%)	—	—
Distribution Solutions Domestic Pharmaceutical Distribution And Services	—	—	—	—	—	—	—	—	—	—	—	—	—	96,185	93,645
Reportable Segment [Member] (Deprecated 2013-01-31)	—	—	—	—	—	—	—	—	—	—	—	—	—	112,084	—
Revenue	403,430	359,051	308,951	276,711	263,966	238,228	231,051	214,319	208,357	198,533	190,884	179,045	137,392	112,084	108,702

Operating income by segment $m, and margin

	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2011	FY2010
Distribution Solutions	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Technology Solutions	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Corporate and other	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Operating income	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡

Revenue by region $m

Line	FY2013	FY2012	FY2011	FY2010	FY2009
United States	112,102 91.74%	112,051 91.60%	102,089 91.08%	99,387 91.43%	98,194 92.09%
International	—	—	9,995 8.92%	9,315 8.57%	8,438 7.91%
Other, not broken out	10,094 8.26%	10,270 8.40%	—	—	—
Revenue	122,196	122,321	112,084	108,702	106,632

As each company reports them in its 10-K and 10-Q filings, in US dollars. Where a later filing recast a year's segments, the year is shown as recast; a period whose breakdown does not add up to the company's revenue is left out.